These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3946089)

  • 21. [Elements with prognostic value in the chronic evolution of viral hepatitis. Markers of the evolution].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):161-70. PubMed ID: 2875504
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of hepatitis B surface antigen and antibody among hospital admitted patients in Manipal.
    Dutta S; Shivananda PG; Chatterjee A
    Indian J Public Health; 1994; 38(3):108-12. PubMed ID: 7774971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH
    Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju].
    Seo JH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):304-14. PubMed ID: 14695697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 27. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
    Romeo F; Russo A; Liuzzo P
    Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
    [No Abstract]   [Full Text] [Related]  

  • 28. Vertical transmission of HBV from mothers HBsAg positive, anti-HBe positive.
    Gussetti N; Pornaro E; Largajolli G; D'Elia R
    Dev Biol Stand; 1983; 54():405-8. PubMed ID: 6653895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen-positive and anti-hepatitis Be-positive carrier mothers.
    Sinatra FR; Shah P; Weissman JY; Thomas DW; Merritt RJ; Tong MJ
    Pediatrics; 1982 Oct; 70(4):557-9. PubMed ID: 7122153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological aspects of HBs antigenemia in patients with hematological malignancies.
    Kościelniak E
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):71-6. PubMed ID: 6477066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunoprevention of hepatitis B in children of HBsAg-positive pregnant patients].
    Fengler JD; Baumgarten R; Markus R; Fischer J; Löschner J; Schwanke H; Küllertz G
    Z Gesamte Inn Med; 1984 Jul; 39(14):326-30. PubMed ID: 6485431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M
    Rev Clin Esp; 1997 Apr; 197(4):248-58. PubMed ID: 9254401
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of hepatitis B markers in Indochinese refugees.
    Chaudhary RK; Nicholls ES; Kennedy DA
    Can Med Assoc J; 1981 Dec; 125(11):1243-6. PubMed ID: 7332883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
    Zaman S; Melia W; Johnson P; White Y; Williams R
    Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 38. [Markers of hepatitis B virus and clinical significances].
    Suzuki F
    Nihon Rinsho; 2011 May; 69 Suppl 4():385-9. PubMed ID: 22096949
    [No Abstract]   [Full Text] [Related]  

  • 39. Global overview of the prevalence of hepatitis B virus markers (HBsAg and anti-HBs) in leprosy patients.
    Moudgil KD; Irshad M
    Trop Gastroenterol; 1988; 9(4):184-90. PubMed ID: 3065990
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of hepatitis B virus markers in children with acute and chronic hepatitis B in the familial spread of the infection].
    Miminoshvili MI; Ketiladze ES; Shakhgil'dian IV; Kozlova TP; Vorozhbieva TE
    Vopr Virusol; 1987; 32(1):63-7. PubMed ID: 3577109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.